Novo, Lilly
Digest more
Zacks.com on MSN
Beyond GLP-1: Eli Lilly's Expanding Drug Portfolio Lifts Sales
LLY???s newest approvals and pipeline deals add fresh momentum to revenue growth as the company expands beyond its GLP-1 ...
Zacks Investment Research on MSN
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Apple became the first $1 trillion company on U.S. public markets in 2018. Six of the eight companies to follow in Apple’s ...
Eli Lilly's stock has captured attention as consensus analyst price targets have risen from $919 to $1,003 per share. This ...
Eli Lilly and Company (NYSE: LLY) is one of the 15 Best Aggressive Growth Stocks to Buy Right Now. On November 7, TD Cowen ...
Eli Lilly’s stock checks all the boxes for a split. the price keeps climbing, the company is on fire, and it’s a bull market.
Eli Lilly stock has regained all-time highs, outpacing rivals in the obesity drug market. Click here to read my latest ...
Lilly's tirzepatide is sold as Mounjaro for Type 2 diabetes and as Zepbound for weight loss -- but doctors have prescribed ...
In the preceding three months, 12 analysts have released ratings for Eli Lilly (NYSE: LLY ), presenting a wide array of perspectives from bullish to bearish. The following table summarizes their ...
We recently published 8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development. Eli Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback